SenesTech (NASDAQ: SNES)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.190 | 0.0200 | ||||
REV | 200.000K | 195.000K | -5.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Cingulate (NASDAQ:CING), Dermata Therapeutics (NASDAQ:DRMA), Pulmatrix (NASDAQ:PULM), Baudax Bio (NASDAQ:BXRX) and Titan Pharmaceuticals (NASDAQ:TTNP).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Wednesday, January 20, 2021. The analyst firm set a price target for 4.00 expecting SNES to rise to within 12 months (a possible 608.47% upside). 0 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $0.5646 last updated June 28, 2022, 8:00 PM UTC.
There are no upcoming dividends for SenesTech.
SenesTech’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.